Hypertension can affect your mind, heart, eyes and more, often without causing any obvious symptoms at all.
Sotatercept improves exercise capacity and delays the time to clinical worsening in patients with World Health Organization (WHO) functional class II or III pulmonary arterial hypertension. The ...
Panelists discuss how riociguat targets the nitric oxide pathway and is approved for both Group 1 PAH and Group 4 chronic thromboembolic pulmonary hypertension, with specific patient selection ...
This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello and welcome to this Medscape InDiscussion on pulmonary arterial hypertension (PAH). Our topic today is the very important ...
Panelists discuss how the future of PAH treatment looks promising with potential for disease remission through reverse remodeling agents, emphasizing the need for continued research focus on patients ...
HONOLULU -- Are the updated European guidelines on pulmonary arterial hypertension (PAH) applicable to American practice? The European Society of Cardiology and European Respiratory Society guidelines ...
Pulmonary hypertension is characterized by increased BP in the pulmonary vasculature You will want your patients to consult a specialist to slow progression of this debilitating disease. Here's what ...
The FDA approved sotatercept (Winrevair) for treating pulmonary arterial hypertension (PAH) in adults, Merck announced on Tuesday. A novel activin signaling inhibitor, sotatercept is indicated to ...
United Therapeutics has linked a once-daily drug candidate to a 55% drop in the risk of clinical worsening in a phase 3 trial ...
Doctors are increasingly noticing early signs of arterial ageing in people in their 30s. Regular health screening and lifestyle changes can help slow or even reverse early vascular damage. Awareness ...
A SIGH OF RELIEF. I THINK THE SCARIEST PART OF MY WHOLE JOURNEY WAS THAT HEART ATTACK IN GREECE. KATRINA, BARRY NEVER SAW IT COMING IN A HEALTHY PERSON HER WHOLE LIFE. AT AGE 25, SHE WAS NOW GASPING ...